We are live on
!
Find out more
PFM
Privium Fund Management Portfolio holdings
AUM
$480M
1-Year Est. Return
77.45%
This Fund
S&P 500
This Quarter
Est. Return
+47.05%
1 Year Est. Return
+77.45%
3 Year Est. Return
+410.34%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$442M
AUM Growth
+$39.9M
(+9.9%)
Cap. Flow
-$47.3M
Cap. Flow
% of AUM
-10.69%
Top 10 Holdings %
Top 10 Hldgs %
74.18%
Holding
92
New
10
Increased
24
Reduced
15
Closed
28
Top Buys
| 1 |
NuScale Power
SMR
|
+$7.43M |
| 2 |
Arcutis Biotherapeutics
ARQT
|
+$3.57M |
| 3 |
Moderna
MRNA
|
+$2.01M |
| 4 |
IONQ.WS
IonQ Inc Warrants
IONQ.WS
|
+$1.9M |
| 5 |
Rocket Pharmaceuticals
RCKT
|
+$1.55M |
Top Sells
| 1 |
AST SpaceMobile
ASTS
|
+$17.3M |
| 2 |
Datadog
DDOG
|
+$7.57M |
| 3 |
Advanced Micro Devices
AMD
|
+$7.22M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$6.63M |
| 5 |
Palantir
PLTR
|
+$6.12M |
Sector Composition
| 1 | Consumer Discretionary | 32.85% |
| 2 | Healthcare | 24.76% |
| 3 | Technology | 23.63% |
| 4 | Communication Services | 14.68% |
| 5 | Industrials | 1.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Roivant Sciences
ROIV
$25.1B
| $2.55M | 0.58% |
215,506
-268,994
| -56% | -$3.18M |
|
|
27
AST SpaceMobile
ASTS
$20.6B
| $2.35M | 0.53% |
111,500
-709,767
| -86% | -$17.3M |
|
28
Microsoft
MSFT
$2.86T
| $2.11M | 0.48% |
5,000
-5,000
| -50% | -$2.13M |
|
29
Krystal Biotech
KRYS
$10B
| $1.45M | 0.33% |
9,250
+2,900
| +46% | +$514K |
|
30
CRISPR Therapeutics
CRSP
$4.97B
| $1.38M | 0.31% |
34,997
+4,650
| +15% | +$220K |
|
31
MeiraGTx Holdings
MGTX
$1.15B
| $1.37M | 0.31% |
225,078
+11,118
| +5% | +$65.2K |
|
32
Ambev
ABEV
$47.7B
| $1.21M | 0.27% |
652,357
+30,043
| +5% | +$66.5K |
|
33
Wave Life Sciences
WVE
$1.18B
| $1.09M | 0.25% |
88,000
+39,166
| +80% | +$523K |
|
|
RNAM
34
DELISTED
Avidity Biosciences
RNAM
| $928K | 0.21% |
31,900
+6,300
| +25% | +$263K |
|
35
Lexeo Therapeutics
LXEO
$363M
| $909K | 0.21% |
+138,115
| New | +$1.09M |
|
36
ALX Oncology
ALXO
$269M
| $850K | 0.19% |
509,059
| – | – |
|
37
Recursion Pharmaceuticals
RXRX
$1.77B
| $804K | 0.18% |
119,000
+41,000
| +53% | +$276K |
|
|
CMPOW
38
DELISTED
CompoSecure Inc Warrant
CMPOW
| $692K | 0.16% |
+148,853
| New | +$685K |
|
39
4D Molecular Therapeutics
FDMT
$612M
| $674K | 0.15% |
121,000
+22,500
| +23% | +$177K |
|
40
Valaris
VAL
$5.44B
| $627K | 0.14% |
14,182
+6,571
| +86% | +$316K |
|
41
NOV
NOV
$6.93B
| $626K | 0.14% |
42,889
+4,964
| +13% | +$77.5K |
|
42
American International
AIG
$41.9B
| $584K | 0.13% |
8,024
| – | – |
|
43
Pfizer
PFE
$138B
| $583K | 0.13% |
21,978
| – | – |
|
|
AUTL
44
Autolus Therapeutics
AUTL
$386M
| $544K | 0.12% |
231,674
+46,035
| +25% | +$156K |
|
45
Dyne Therapeutics
DYN
$3.93B
| $480K | 0.11% |
20,366
+5,350
| +36% | +$158K |
|
46
Pan American Silver
PAAS
$18.3B
| $430K | 0.1% |
21,284
-5,200
| -20% | -$116K |
|
47
Sprott Uranium Miners ETF
URNM
$1.86B
| $414K | 0.09% |
10,276
+1,420
| +16% | +$66.1K |
|
|
SA
48
Seabridge Gold
SA
$2.78B
| $411K | 0.09% |
35,987
+3,900
| +12% | +$60.1K |
|
|
EMX
49
DELISTED
EMX Royalty
EMX
| $375K | 0.08% |
+216,968
| New | +$388K |
|
50
Franco-Nevada
FNV
$39.1B
| $350K | 0.08% |
2,977
-3,084
| -51% | -$381K |
|
Similar funds
FCM
DA
YLHM
BFA
HC
LIM
TAA
NQWM